Bioorganic and Medicinal Chemistry Letters p. 533 - 538 (1999)
Update date:2022-08-03
Topics:
Nomura, Masahiro
Kinoshita, Susumu
Satoh, Hiroya
Maeda, Toshio
Murakami, Koji
Tsunoda, Masaki
Miyachi, Hiroyuki
Awano, Katsuya
A series of 3-[(2,4-dioxothiazolidin-5-yl)methyl]benzamide derivatives was prepared as part of a search for antidiabetic agents. A structure- activity relationship study of these compounds led to the identification of 5-[(2,4-dioxothiazolidin-5-yl)methyl]-2-methoxy-N-[[4- (trifluoromethyl)phenyl]methyl]benzamide (KRP-297) as a candidate drug for the treatment of diabetes mellitus.
View MoreChengdu Boon Stream Chemical Industry Co.,Ltd.
Contact:+86-28-83156758
Address:No.859,Dongzikou Road,Jinniu District,Chengdu,Sichuan,P.R.China
Jintan City Mego Chemical Co., Ltd
Contact:+86-0519-82814387
Address:23# Dengguan Town, Jintan, Jiangsu Province, China
Shanghai Sinofluoro Scientific Co., Ltd
Contact:+86-21-64279360
Address:Room 1006,Building 3,#58 East Xinjian Road, Shanghai ,201100,China,
website:http://www.sagechem.com
Contact:+86-571-86818502
Address:Room C1301, New Youth Plaza, 8 Jia Shan Road, Hangzhou, China
Suzhou Lixin Pharmaceutical Co., Ltd.
Contact:86-512-88169812
Address:21 Tangxi Road, Suzhou New District, Suzhou 215151
Doi:10.1002/anie.201701691
(2017)Doi:10.1016/S0040-4020(98)00102-1
(1998)Doi:10.1016/S0957-4166(98)00040-8
(1998)Doi:10.1021/ja01018a027
(1968)Doi:10.1016/j.jorganchem.2015.07.017
(2015)Doi:10.1002/cmdc.201700243
(2017)
